Aimfinity Investment Corp. I Files 8-K on Equity Issuance
Ticker: AIMTF · Form: 8-K · Filed: Dec 4, 2025 · CIK: 1903464
Sentiment: neutral
Topics: equity-issuance, warrants, unregistered-sales
Related Tickers: AIMTF
TL;DR
AIMTF issued new units with warrants, exercise price $11.50.
AI Summary
Aimfinity Investment Corp. I filed an 8-K on December 4, 2025, reporting on unregistered sales of equity securities and a direct financial obligation. The filing details the issuance of new units, including ordinary shares and redeemable warrants, with exercise prices of $11.50, effective November 28, 2025.
Why It Matters
This filing indicates the company has issued new equity, which could dilute existing shareholders or provide capital for future operations.
Risk Assessment
Risk Level: medium — The issuance of new equity and warrants can lead to dilution and uncertainty about the company's financial structure.
Key Numbers
- $11.50 — Warrant Exercise Price (Price at which warrants can be exercised for Class A ordinary shares.)
Key Players & Entities
- Aimfinity Investment Corp. I (company) — Filer of the 8-K
- 0001213900-25-118259 (filing_id) — Accession Number for the filing
- 20251204 (date) — Filing date
- 2025-11-28 (date) — Effective date of equity issuance
- 11.50 (dollar_amount) — Exercise price for warrants
FAQ
What specific types of equity securities were sold?
The filing mentions the sale of 'Units Consisting Of One New Unit And One Class 1 Redeemable Warrant Each Exercisable For One Class A Ordinary Share' and 'New Units Consisting Of One Class Ordinary Share And One-half Of One Class 2 Redeemable Warrant Each Full Exercisable For One Class A Ordinary Share'.
What is the exercise price for the warrants mentioned?
The exercise price for both Class 1 and Class 2 redeemable warrants is $11.50 per share.
On what date did these unregistered sales of equity securities become effective?
The effective date for these issuances is November 28, 2025.
What is the SEC file number for Aimfinity Investment Corp. I?
The SEC file number for Aimfinity Investment Corp. I is 001-41361.
What are the main items reported in this 8-K filing?
The filing reports on the Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, and Financial Statements and Exhibits.
Filing Stats: 2,529 words · 10 min read · ~8 pages · Grade level 15.9 · Accepted 2025-12-04 15:31:29
Key Financial Figures
- $11.50 — ordinary share at an exercise price of $11.50 AIMUF OTC Market Group, Inc. New
- $500 — s trust account (the " Trust Account ") $500 for each one-month extension. In addit
- $5,000,001 — o have net tangible assets of less than $5,000,001. On November 28, 2025, the Company iss
- $10.00 — rdinary shares at a conversion price of $10.00 per share. The Note was issued pursuant
Filing Documents
- ea0268542-8k425_aimfin1.htm (8-K) — 48KB
- ea026854201ex10-1_aimfinity1.htm (EX-10.1) — 30KB
- ea026854201ex99-1_aimfinity1.htm (EX-99.1) — 15KB
- ex99-1_001.jpg (GRAPHIC) — 13KB
- 0001213900-25-118259.txt ( ) — 349KB
- aimtf-20251128.xsd (EX-101.SCH) — 4KB
- aimtf-20251128_def.xml (EX-101.DEF) — 27KB
- aimtf-20251128_lab.xml (EX-101.LAB) — 38KB
- aimtf-20251128_pre.xml (EX-101.PRE) — 26KB
- ea0268542-8k425_aimfin1_htm.xml (XML) — 7KB
03 Creation of a Direct Financial Obligation or an Obligation
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant On October 27, 2025, Aimfinity Investment Corp. I, a Cayman Islands exempted company (the " Company " or " AIMA "), held an extraordinary general meeting (the " EGM "), where the shareholders of the Company approved an amendment (the " Extension Amendment ") to the Company's fourth amended and restated memorandum and articles of associations (the " Charter ") to allow the Company until October 28, 2025 to consummate an initial business combination and may elect to extend the period to consummate an initial business combination up to nine times, each by an additional one-month period (each, a " Monthly Extension "), for a total of up to nine months to July 28, 2026, by depositing into the Company's trust account (the " Trust Account ") $500 for each one-month extension. In addition, the shareholders, by special resolutions, also approved an amendment (the " NTA Amendment ") to the Charter to remove the requirement that the Company may not consummate a business combination or redeem public shares of the Company that would cause the Company to have net tangible assets of less than $5,000,001. On November 28, 2025, the Company issued an unsecured promissory note of $500 (the " Note ") to I-Fa Chang, a member and manager of Aimfinity Investment LLC, the sponsor of the company (the " Sponsor "), as the Sponsor's designee, to evidence the payments made for $500 (the " New Monthly Extension Payment ") to be deposited into the Trust Account for the public shareholders, which enables the Company to extend the period of time it has to consummate its initial business combination by one month from November 28, 2025 to December 28, 2025 (the " New Extension "). The New Extension is the first of the up to nine Monthly Extensions permitted under the Extension Amendment. Pursuant to the Note, and a certain exchange agreement, dated April 8, 2025, by and am
02 Unregistered Sales of Equity Securities
Item 3.02 Unregistered Sales of Equity Securities. The information disclosed under Item 2.03 of this Current Report on Form 8-K is incorporated by reference into this Item 3.02 to the extent required herein.
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On December 4, 2025, the Company issued a press release (the " Press Release ") announcing the New Extension. A copy of the Press Release is furnished as Exhibit 99.1 hereto. The information in this Item 7.01 and Exhibit 99.1 furnished hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the " Exchange Act "), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing. IMPORTANT NOTICES As disclosed previously on the Current Report on Form 8-K filed with the Securities and Exchange Commission (the "SEC") on October 16, 2023, on October 13, 2023, AIMA entered into that certain Merger Agreement, with Docter, Aimfinity Investment Merger Sub I (the "Purchaser" or "PubCo"), and Aimfinity Investment Merger Sub II, Inc. (the "Merger Sub"), pursuant to which AIMA will complete a business combination (the "Business Combination") with Docter that involves a reincorporation merger and an acquisition merger. 1 This Current Report on Form 8-K contains certain "forward-looking about the proposed transactions described above, and the parties' perspectives and expectations, are forward-looking statements. Such statements include, but are not limited to, statements regarding the proposed transactions, including the anticipated initial enterprise value and post-closing equity value, the benefits of the proposed transaction, integration plans, expected synergies and revenue opportunities, anticipated future financial and operating performance and results, including estimates for growth, the expected management and governance of the combined company, and the expected timing of
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1 Promissory Note, dated November 28, 2025, issued by Aimfinity Investment Corp. I to I-Fa Chang 99.1 Press Release, dated December 4, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 3
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Aimfinity Investment Corp. I Date: December 4, 2025 By: /s/ I-Fa Chang Name: I-Fa Chang Title: Chief Executive Officer 4